Dozens of gut bacteria associated with multiple sclerosis
How improving COPD treatment in primary care could reduce demand on hospitals and emergency departments
15 September 2022Sharing of skin microbiome between children with atopic dermatitis and healthy contacts might contribute to recurrence
15 September 2022Dozens of gut bacteria associated with multiple sclerosis
An international research consortium led by UC San Francisco scientists has shown significant differences between the gut bacteria profiles of multiple sclerosis (MS) patients and healthy individuals, as well as between MS patients receiving different drug treatments. While some of these changes had been reported before, most are reported for the first time. The group also uncovered novel mechanisms by which these bacteria may potentially influence disease development and treatment response.
